Key Highlights

  • SkinKandy Limited (ASX:SK1) reported pro forma FY26 Revenue of $90.2 million, up 29%, with pro forma EBITDA of $24.6 million and net profit after tax of $9.0 million.
  • The company opened 22 studios in FY26 to finish the year with 109, and says it has since opened nine more, taking the network to 118.
  • Unaudited revenue for the first 19 weeks of FY27 to 14 November rose 21% on the prior corresponding period.
  • South Africa is the first planned market beyond Australia and New Zealand, with first studios expected in the second half of FY27.

SkinKandy Limited (ASX:SK1), which describes itself as Australia and New Zealand’s leading piercing specialist, held its first Annual General Meeting as a listed company on 19 November 2026. Chief Executive Dain Friis’ address included a trading update and outlook for FY27. The company’s figures are presented on a pro forma basis for FY26 and on an unaudited basis for the current year to date.

FY26 Results as a Listed Company

The company reported pro forma revenue of $90.2 million for FY26, up 29% and 2% ahead of its prospectus forecast. Like-for-like growth was 9.6%, compared with a forecast of 8.1%. Pro forma EBITDA was $24.6 million and net profit after tax was $9.0 million, both up 41%. Cash reserves at year end were $13.8 million, with no drawn debt.

The Board said the company was ahead of its prospectus forecast on all key measures in its first year as a listed entity. The Board has not declared a final Dividend for FY26, in line with the prospectus.

Growth Drivers and Studio Economics

Management identifies three growth drivers: the piercer network, studio Economics and international expansion. The company now has more than 850 SK Certified piercers, and it says its Training program builds capability as the network grows. Gross Margin was consistent with FY26, and the company says its offers are value-led rather than driven by seasonal discounting.

SkinKandy has added a General Manager Retail and a General Manager Technology and Transformation, and has launched an enhanced piercing training program. The Board has also set out a longer-term potential of 180 to 210 studios in Australia and New Zealand, with 18 to 20 new studios planned in FY27 in those markets, plus 5 to 7 refurbishments, relocations and upsizes.

Trading Update and Customer Conditions

For the first 19 weeks to 14 November, unaudited revenue was up 21% on the prior corresponding period. Studios opened since the IPO are trading in line with expectations, and the company has opened nine studios so far this year, including Merrylands. Management acknowledged that some customers are feeling the economic environment, although Demand for piercing has held up.

Looking at international growth, South Africa is described as progressing well, with a country manager in place and multiple sites under negotiation. The company expects its first studios outside Australia and New Zealand in the second half of FY27.

Looking Ahead

The company expects 10 to 12 openings in the first half of FY27 and says it is on track for its 18 to 20 new-studio target in Australia and New Zealand. The first South African studios and the peak Christmas trading period will be the next points to track.